"Skagit Valley Hospital features a full range of services including surgery; Level III Emergency Department; Family Birth Center; diagnostics; and advanced heart and vascular care."

During the past decade, Skagit Valley Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 59 clinical trials were completed, i.e. on average, 218.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 30 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skagit Valley Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "University of Washington" with 6 trials sponsored and "Radiation Therapy Oncology Group" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skagit Valley Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Skagit Valley Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials) and "Recurrent Melanoma" (6 trials). Many other conditions were trialed in "Skagit Valley Hospital" in a lesser frequency.

Most popular intervention types in "Skagit Valley Hospital" are "Drug" (75 trials), "Other" (60 trials), "Biological" (35 trials), "Procedure" (13 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Quality-of-Life Assessment" (12 trials), "Paclitaxel" (9 trials), "Bevacizumab" (8 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Skagit Valley Hospital" are 75 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Skagit Valley Hospital". undefined are not yet recruiting, 5 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Skagit Valley Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Skagit Valley Hospital, 4 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".